Repetitive low-volume blood sampling method as a feasible monitoring tool in a mouse model of sepsis

Katrin M Weixelbaumer1, Pierre Raeven, Heinz Redl

  • 1Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in the Trauma Research Center of AUVA, Vienna, Austria.

Insights

Daily blood collection in septic mice is safe and reliable for immunoinflammatory monitoring. Small sample volumes (20 μL) minimize impact on hematologic parameters, ensuring accurate sepsis research.

Area of Science:

  • Critical illness research
  • Animal models of sepsis
  • Immunoinflammatory monitoring

Background:

  • Accurate monitoring of immunoinflammatory and organ function is crucial in critical illness models.
  • Repetitive blood collection in diseased mice can be invasive and affect experimental outcomes.
  • Developing minimally invasive methods for longitudinal monitoring in sepsis models is essential.

Purpose of the Study:

  • To assess the impact of daily blood sampling on survival and key parameters in a mouse model of acute sepsis.
  • To evaluate the reliability of complete blood cell counts using resuspended blood cells.
  • To determine optimal blood collection volumes for safe and effective immunomonitoring in septic mice.

Main Methods:

  • Female OF-1 and CD-1 mice underwent cecal ligation and puncture (CLP) to induce sepsis.
  • Mice were divided into daily (1-5 days) and Day 5 sampling groups, with tested volumes of 20 μL and 35 μL.
  • Hematologic parameters, organ function markers, and survival were analyzed; complete blood cell counts were validated using resuspended cells.

Main Results:

  • Daily blood collection did not significantly affect 14-day survival post-CLP.
  • Larger sample volumes (35 μL) in OF-1 mice led to decreased red blood cell count and hemoglobin.
  • Smaller volumes (20 μL) showed minimal impact, with only a slight hemoglobin decrease in OF-1 mice; urea increased in the Daily group (20 μL).
  • Complete blood cell counts correlated well between regular and resuspended samples (r ≥ 0.9), except for lymphocytes.

Conclusions:

  • Daily blood sampling, particularly with 20 μL volumes, is a feasible and safe method for longitudinal immunoinflammatory monitoring in mouse sepsis models.
  • The findings support the translation of clinically relevant daily monitoring to preclinical sepsis research.
  • Resuspension of blood cells offers a reliable method for complete blood cell count analysis in this context.

Related Concept Videos